The Discounted Cash Flow (DCF) valuation of CureVac NV (CVAC) is (0.81) USD. With the latest stock price at 4.66 USD, the upside of CureVac NV based on DCF is -117.3%.
Based on the latest price of 4.66 USD and our DCF valuation, CureVac NV (CVAC) is a sell. selling CVAC stocks now will result in a potential gain of 117.3%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 8.9% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (3.93) - 0.15 | (0.81) |
| Upside | -184.2% - -96.7% | -117.3% |